Quarterly report [Sections 13 or 15(d)]

Stockholders’ Equity (Tables)

v3.26.1
Stockholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Summary of Share-Based Compensation Expense The following table sets forth share-based compensation expense included in the condensed consolidated statements of operations:

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Cost of revenue

 

$

52

 

 

$

37

 

 

$

104

 

 

$

69

 

Research and development costs

 

 

499

 

 

 

573

 

 

 

972

 

 

 

1,056

 

Sales and marketing expenses

 

 

666

 

 

 

633

 

 

 

1,318

 

 

 

1,125

 

General and administrative expenses

 

 

1,054

 

 

 

1,026

 

 

 

2,095

 

 

 

1,927

 

Total share-based compensation expense

 

$

2,271

 

 

$

2,269

 

 

$

4,489

 

 

$

4,177

 

Share-based compensation expense by type of share-based award is summarized below:

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Stock options

 

$

—

 

 

$

83

 

 

$

28

 

 

$

193

 

RSAs and RSUs

 

 

2,149

 

 

 

2,115

 

 

 

4,192

 

 

 

3,842

 

ESPP

 

 

122

 

 

 

71

 

 

 

269

 

 

 

142

 

Total share-based compensation expense

 

$

2,271

 

 

$

2,269

 

 

$

4,489

 

 

$

4,177

 

Total unrecognized compensation expense by type of award and the weighted-average remaining requisite service period over which such expense is expected to be recognized:

 

June 30, 2026

 

 

Unrecognized
Expense
(in thousands)

 

 

Remaining
Weighted-
Average
Recognition
Period (in years)

 

RSUs

 

$

14,329

 

 

 

2.06

 

 
Summary of Stock Option Activity

Stock option activity for the six months ended June 30, 2026 is summarized below:

 

Stock
Options

 

 

Weighted-
average
Exercise
price
per share

 

 

Weighted-
average
Remaining
Contractual
Life (in years)

 

 

Intrinsic
Value
(in thousands)(1)

 

Outstanding as of December 31, 2025

 

 

1,302,072

 

 

$

5.78

 

 

 

 

 

 

 

Exercised

 

 

(211,871

)

 

$

3.27

 

 

 

 

 

 

 

Forfeited or expired

 

 

(1,875

)

 

$

12.40

 

 

 

 

 

 

 

Outstanding as of June 30, 2026

 

 

1,088,326

 

 

$

6.26

 

 

 

3.55

 

 

$

12,715

 

Exercisable as of June 30, 2026

 

 

1,088,326

 

 

$

6.26

 

 

 

3.55

 

 

$

12,715

 

 

(1)

Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.
Schedule of Restricted Stock Unit Activity

Restricted Stock Unit Activity

Restricted stock unit (“RSU”) activity for the six months ended June 30, 2026 is summarized below:

 

Restricted Stock
Units

 

 

Weighted-
Average
Grant
Date Fair Value

 

Outstanding as of December 31, 2025

 

 

1,651,867

 

 

$

9.16

 

Granted

 

 

780,714

 

 

$

13.32

 

Vested

 

 

(841,454

)

 

$

8.28

 

Forfeited or expired

 

 

(29,271

)

 

$

12.27

 

Outstanding as of June 30, 2026

 

 

1,561,856

 

 

$

11.65